• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Lipids: Update on Diagnosis and Management of Dyslipidemia, An Issue of Endocrinology and Metabolism Clinics of North America

Lipids: Update on Diagnosis and Management of Dyslipidemia, An Issue of Endocrinology and Metabolism Clinics of North America

9780323986953
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
529,15 zł
449,78 zł Zniżka 79,37 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 449,78 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of Lipids:: Update on Diagnosis and Management of Dyslipidemia. When untreated, dyslipidemia may have serious comorbidities; in this issue, top experts cover the evaluation and management of LDL cholesterol and high triglicerides in adults and children, providing practical information that will help physicians and other health care professionals treat their patients and improve outcomes.
Szczegóły produktu
Elsevier
93970
9780323986953
9780323986953

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
450
  • Lipid and Lipoprotein Metabolism
    Lipoprotein Assessment in the twenty-first Century
    Assessment of Cardiovascular Disease Risk: A 2022 Update
    The Inherited Hypercholesterolemias
    Hypertriglyceridemia
    High-Density Lipoprotein and Cardiovascular Disease-Where do We Stand?
    Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents
    Management of Dyslipidemia in Endocrine Diseases
    Dyslipidemia in Diabetes: When and How to Treat?
    Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease
    New and Emerging Therapies for Dyslipidemia
    Safety of Statins and Nonstatins for Treatment of Dyslipidemia
    LDL Cholesterol-How Low Can We Go?
Komentarze (0)